Stock 600664 HARBIN PHARMACEUTICAL GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Harbin Pharmaceutical Group Co., Ltd.

Equities

600664

CNE0000009T3

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-05-12 pm EDT 		5-day change 1st Jan Change
3.13 CNY -0.95% Intraday chart for Harbin Pharmaceutical Group Co., Ltd. -0.95% -6.57%
Apr. 25 Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 11 Harbin Pharma to Upgrade Subsidiary's Production Base for 50 Million Yuan MT

Business Summary

Harbin Pharmaceutical Group Co is a China-based company mainly engaged in pharmaceutical research and development. The Company's main businesses are innovative research and development in high-tech fields such as antibiotics, modern Chinese medicine, and biopharmaceuticals, covering the business sectors of antibiotics, over-the-counter drugs and health products, traditional and modern Chinese medicine, biomedicine, and pharmaceutical commerce. The Company’s main products include calcium gluconate oral solution, zinc gluconate oral solution, amoxicillin capsules, Shuanghuanglian oral solution, alprostadil injection, pediatric paracetamol Huangnamin granules, lacidipine tablets, hydrochloric acid for injection Cefotiam, ibuprofen granules, Xingaizhonggai high calcium tablets, etc.

Number of employees: 9,853

Sales per Business

CNY in Million2022Weight2023Weight Delta
Wholesale Medical
39.8 %
5,930 42.9 % 6,150 39.8 % +3.71%
Nutritional Supplements
18.5 %
2,034 14.7 % 2,865 18.5 % +40.84%
Wholesale Commercial
16.2 %
2,135 15.5 % 2,501 16.2 % +17.14%
Retail
10.4 %
1,450 10.5 % 1,601 10.4 % +10.35%
Anti-virus and Anti-infection
6.6 %
886 6.4 % 1,016 6.6 % +14.67%
Cold Medicine
3.5 %
584 4.2 % 536 3.5 % -8.12%
Digestive System
1.7 %
300 2.2 % 256 1.7 % -14.44%
Cardiovascular
1.4 %
290 2.1 % 222 1.4 % -23.69%
Inter-Segment Offset
-1.4 %
-292 -2.1 % -219 -1.4 % -24.85%
Anti-tumor
1.4 %
157 1.1 % 214 1.4 % +36.46%
Industrial - Others
1.0 %
198 1.4 % 161 1.0 % -18.78%
Commercial - Others
0.6 %
82 0.6 % 97 0.6 % +18.69%
Other Business
0.4 %
54 0.4 % 56 0.4 % +4.82%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
93.1 %
13,456 97.4 % 14,388 93.1 % +6.93%
Overseas
6.9 %
353 2.6 % 1,069 6.9 % +202.80%

Managers

Managers TitleAgeSince
Bo Liu DFI
 Director of Finance/CFO 61 08-09-25
Kun Yu Ma IRC
 Investor Relations Contact 43 14-04-30
Xiao Dong Meng SEC
 Corporate Secretary 52 04-12-23

Members of the board

Members of the board TitleAgeSince
Xiao Dong Meng SEC
 Corporate Secretary 52 04-12-23
Ai Dong Lou BRD
 Director/Board Member 58 21-01-07
Bo Liu DFI
 Director of Finance/CFO 61 08-09-25
Zhao Hua Li BRD
 Director/Board Member 58 21-01-07
Xiao Ping Hu CHM
 Chairman 54 22-06-26
Ying Lei BRD
 Director/Board Member 67 Dec. 26

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,521,278,976 1,221,919,310 ( 48.46 %) 2,769,100 ( 0.1098 %) 48.46 %

Shareholders

NameEquities%Valuation
Harbin Pharmaceutical Group Holding Co., Ltd.
46.60 %
1,173,237,023 46.60 % 502 M ¥
China State-Owned Assets Supervision & Admn Commission
2.213 %
55,725,125 2.213 % 24 M ¥
Fullgoal Fund Management Co., Ltd.
1.247 %
31,389,992 1.247 % 13 M ¥
Zhejiang Zhecai Capital Management Co. , Ltd.
0.9487 %
23,883,418 0.9487 % 10 M ¥
Kun Sun
0.7944 %
20,000,000 0.7944 % 9 M ¥
Shanghai State-Owned Assets Supervision & Administration
0.6377 %
16,055,000 0.6377 % 7 M ¥
Yong Lian
0.6294 %
15,844,800 0.6294 % 7 M ¥
Chong Yang Xia
0.5640 %
14,200,000 0.5640 % 6 M ¥
China Merchants Fund Management Co., Ltd.
0.0958 %
2,410,900 0.0958 % 1 M ¥
China Asset Management Co., Ltd.
0.0765 %
1,924,832 0.0765 % 824 001 ¥

Company contact information

Harbin Pharmaceutical Group Co., Ltd.

7 Qunli Avenue Daoli District

150070, Harbin

+86 45 1518 70240

http://www.hayao.com
address Harbin Pharmaceutical Group Co., Ltd.(600664)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
HARBIN PHARMACEUTICAL GROUP CO., LTD. Stock Harbin Pharmaceutical Group Co., Ltd.
-6.57% 1.1B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+29.98% 684B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+30.34% 568B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.52% 361B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.59% 329B
ABBVIE INC. Stock AbbVie Inc.
+4.07% 284B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.21% 240B
NOVARTIS AG Stock Novartis AG
+9.66% 208B
ROCHE HOLDING AG Stock Roche Holding AG
-6.83% 200B
AMGEN INC. Stock Amgen Inc.
+7.09% 166B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600664 Stock
  4. Company Harbin Pharmaceutical Group Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW